PlumX Metrics
Embed PlumX Metrics

How does bacillus thuringiensis crystallize such a large diversity of toxins?

Toxins, ISSN: 2072-6651, Vol: 13, Issue: 7
2021
  • 10
    Citations
  • 0
    Usage
  • 45
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    10
  • Captures
    45
  • Mentions
    2
    • Blog Mentions
      1
      • Blog
        1
    • References
      1
      • Wikipedia
        1

Most Recent Blog

Toxins, Vol. 13, Pages 443: How Does Bacillus thuringiensis Crystallize Such a Large Diversity of Toxins?

Toxins, Vol. 13, Pages 443: How Does Bacillus thuringiensis Crystallize Such a Large Diversity of Toxins? Toxins doi: 10.3390/toxins13070443 Authors: Guillaume Tetreau Bacillus thuringiensis (Bt)

Review Description

Bacillus thuringiensis (Bt) is a natural crystal-making bacterium. Bt diversified into many subspecies that have evolved to produce crystals of hundreds of pesticidal proteins with radically different structures. Their crystalline form ensures stability and controlled release of these major virulence factors. They are responsible for the toxicity and host specificity of Bt, explaining its worldwide use as a biological insecticide. Most research has been devoted to understanding the mechanisms of toxicity of these toxins while the features driving their crystallization have long remained elusive, essentially due to technical limitations. The evolution of methods in structural biology, pushing back the limits of the resolution attainable, now allows access to be gained to structural information hidden within natural crystals of such toxins. In this review, I present the main parameters that have been identified as key drivers of toxin crystallization in Bt, notably in the light of recent discoveries driven by structural biology studies. Then, I develop how the future evolution of structural biology will hopefully unveil new mechanisms of Bt toxin crystallization, opening the door to their hijacking with the aim of developing a versatile in vivo crystallization platform of high academic and industrial interest.

Bibliographic Details

Tetreau, Guillaume; Andreeva, Elena A; Banneville, Anne-Sophie; De Zitter, Elke; Colletier, Jacques-Philippe

MDPI AG

Pharmacology, Toxicology and Pharmaceutics; Environmental Science

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know